Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety

Olgun H., CEVİZ N., KARTAL I., Caner I., KARACAN M., TAŞTEKİN A., ...Daha Fazla

PEDIATRICS AND NEONATOLOGY, cilt.58, sa.1, ss.29-35, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.pedneo.2015.04.017
  • Dergi Adı: PEDIATRICS AND NEONATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.29-35
  • Anahtar Kelimeler: ibuprofen, multiple course, patent ductus arteriosus, preterm infants, BIRTH-WEIGHT INFANTS, BILIRUBIN-ALBUMIN BINDING, PRETERM INFANTS, MULTIPLE COURSES, CONTROLLED-TRIAL, RISK-FACTORS, INDOMETHACIN, CLOSURE, PROPHYLAXIS
  • Atatürk Üniversitesi Adresli: Evet

Özet

BACKGROUND: There are limited data about the results of repeated oral ibuprofen (OIBU) treatment. This study aimed to describe patent ductus arteriosus (PDA) closure rates and adverse events after repeated courses of OIBU in premature infants with PDA.